Gamida Cell Ltd (NASDAQ:GMDA)
| 1.97 Delayed Data As of May 26 |  -0.01 / -0.51%Today’s Change | 0.56 Today|||52-Week Range 3.66 | +52.71% Year-to-Date |
Latest GMDA News | Press Releases
No recent news for Gamida Cell Ltd.
Today’s Trading
| Previous close | 1.98 |
| Today’s open | 1.99 |
| Day’s range | 1.95 - 1.99 |
| Volume | 45,393 |
| Average volume (3 months) | 3,743,442 |
| Market cap | $207.0M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +17.95% |
| Earnings growth (this year) | +38.87% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CARMCarisma Therapeutics... | +0.35 | +7.29% |
| ---- | ||
| AKBAAkebia Therapeutics ... | -0.08 | -7.02% |
| EYPTEyePoint Pharmaceuti... | +0.05 | +0.84% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$79.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
